Conrad Wilson Hummel

Title: Conrad Wilson Hummel: Innovator in Selective Estrogen Receptor Modulators

Introduction

Conrad Wilson Hummel is a notable inventor based in Louisville, Colorado. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective estrogen receptor modulators. With a total of two patents to his name, Hummel's work is focused on innovative treatments for various medical conditions.

Latest Patents

Hummel's latest patents include a selective estrogen receptor modulator for the treatment of osteoarthritis. This invention is directed to a compound of a specific formula or a pharmaceutically acceptable salt thereof. Additionally, he has developed selective estrogen receptor modulators containing a phenylsulfonyl group, which are useful for treating endometriosis and/or uterine leiomyoma.

Career Highlights

Conrad Hummel is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly has allowed him to focus on groundbreaking research and development in the field of women's health.

Collaborations

Hummel has collaborated with notable colleagues, including Jeffrey A. Dodge and Scott Alan Jones. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Conrad Wilson Hummel is a distinguished inventor whose work in selective estrogen receptor modulators has the potential to impact the treatment of various medical conditions. His contributions to the pharmaceutical industry exemplify the importance of innovation in healthcare.